Laura Krick, Mark Rowe, SecurAcath and New Clinical Evidence

ISAVE That Podcast

The ISAVE That Podcast returns from its summer hiatus with a bang! AVA welcomes Laura Krick, Vice President of Clinical and Market Development at Interrad Medical, Inc. and Mark Rowe, MNSc, RNP, VA-BC™, the vascular access team leader at the University of Arkansas, for a discussion on the SecurAcath subcutaneous securement device. How does SecurAcath impact patient safety? We find out, with new clinical evidence provided by Mark and his team in a recent publication.
AVA Director of Communications and Editor-In-Chief of the Journal of the Association for Vascular Access Eric Seger also sits down with 2020 AVA at Your Fingertips D-TEAM Chair Michele Cox, RN, CCRN, VA-BC™ and 2020 AVA President-Elect Jocelyn Grecia Hill, MN, RN, CVAA, VA-BC™ to learn about the decision-making process behind moving from an in-person scientific meeting to a virtual one that opens at the end of October.
0:00 Information from episode sponsor Interrad Medical, Inc.
0:29 Judy and Eric interview Laura and Mark about SecurAcath and the impact it has on preventing Central Line Bloodstream Infections
21:37 Another word from episode sponsor Interrad Medical Inc.
22:26 Eric's discussion with Jocelyn and Michele about the decision to move the 2020 AVA Scientific Meeting from an in-person event to a virtual meeting, AVA at Your Fingertips

Support the show

Capíttulos

1. SecurAcath 1 (00:00:00)

2. New Evidence to Prevent CLABSI from SecurAcath (00:00:29)

3. SecurAcath 2 (00:21:37)

4. AVASM20>>AVA at Your Fingertips (00:22:26)